Brian Bolwell, M.D.
| Appointed: |
1987 |
| Gender: |
Male |
| Languages: |
English |
Hematologic Oncology and Blood Disorders
Taussig Cancer Institute
Transplantation Center
Professional Staff Affairs Office
Vice Chair, Office of the Chief of Staff
Biographical Sketch
Brian Bolwell, MD, is Director of the Bone Marrow Transplant Program at Cleveland Clinic and has held this position since 1988. In 2006, he was appointed as Chairman of the Department of Hematologic Oncology and Blood Disorders. He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and has authored more than 300 articles and abstracts concerning hematologic malignancies and bone marrow transplantation. He also has edited a book entitled “Current Controversies in Bone Marrow Transplantation.” (Humana Press, 2000), and he is co-editor of a recently published textbook entitled “Clinical Malignant Hematology” (McGraw-Hill, 2007).
He attended Harvard University and he received his medical degree from Case Western Reserve University. He completed his medical internship and residency at University Hospitals of Cleveland and completed his hematology/oncology fellowship at the Hospital of the University of Pennsylvania.
Dr. Bolwell is a reviewer for many journals including the Journal of Clinical Oncology, Blood, Annals of Internal Medicine and Bone Marrow Transplantation. He has served, on multiple occasions, as a Bone Marrow Transplant (BMT) abstract reviewer and abstract session coordinating reviewer at the American Society of Hematology Annual meetings.
He has held the position of Chairman of the Board of Trustees of the Ohio Hematopoietic Stem Cell Transplant Consortium for more than 10 years. In 2004, he was elected to the Executive Committee of the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry. He is a member of the Board of Governors of Cleveland Clinic.
Professional Highlights
- Member, Cleveland Clinic Board of Governors
- Chairman, Department of Hematologic Oncology and Blood Disorders
- President of the Cleveland Clinic Professional Staff
- Chairman of the Board, Ohio Bone Marrow Transplant Consortium
- Director, Cleveland Clinic Bone Marrow Transplant Program,1988-Present
Education & Fellowships
| Medical School: | Case Western Reserve University School of Medicine, Cleveland, OH |
|
| Internship: | University Hospitals of Cleveland, Internal Medicine, Cleveland, OH |
| Residency: | University Hospitals of Cleveland, Internal Medicine, Cleveland, OH |
| Fellowship: | Hospital of University of Pennsylvania, Hematology/Oncology, Philadelphia, PA |
| Other Education: | (Undergraduate) Harvard University, Cambridge, MA |
Certifications
Medical Oncology
Internal Medicine
Specialty Interests
Bone Marrow Transplantation, Hodgkin's Disease, Leukemia.
Awards & Honors
- Who's Who in Medicine and Healthcare, 2006-2007
- Castle Connolly Top Doctor Guides for 2007
Professional Memberships
- Chairman, Ohio Bone Marrow Transplant Consortium
- Co-Chair, Late Effects Committee, Center for International Blood and Marrow Transplantation Research
- American Society of Hematology
- American Society of Clinical Oncology
- American Medical Association
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 8/7/2008, Dr. Bolwell has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Royalty Payments. Dr. Bolwell has the right to receive royalty payments for inventions or discoveries related to the companies shown below:
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
